Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Solidago Virgaurea Flowering Top is a non-standardized plant allergenic extract used primarily in diagnostic testing and immunotherapy. It belongs to the class of Non-Standardized Plant Allergenic Extracts [EPC] and is utilized to manage hypersensitivity to goldenrod pollen.
Name
Solidago Virgaurea Flowering Top
Raw Name
SOLIDAGO VIRGAUREA FLOWERING TOP
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
138
Variant Count
161
Last Verified
February 17, 2026
About Solidago Virgaurea Flowering Top
Solidago Virgaurea Flowering Top is a non-standardized plant allergenic extract used primarily in diagnostic testing and immunotherapy. It belongs to the class of Non-Standardized Plant Allergenic Extracts [EPC] and is utilized to manage hypersensitivity to goldenrod pollen.
Detailed information about Solidago Virgaurea Flowering Top
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Solidago Virgaurea Flowering Top.
Solidago Virgaurea Flowering Top, commonly known as European Goldenrod, is a botanical substance that serves multiple roles in clinical pharmacology, primarily classified as a Non-Standardized Plant Allergenic Extract [EPC]. This substance is derived from the flowering tops of the Solidago virgaurea plant, a member of the Asteraceae family. While often misunderstood as a primary cause of hay fever (allergic rhinitis), goldenrod pollen is relatively heavy and sticky, usually requiring insect transport rather than being windborne. However, for sensitized individuals, exposure can trigger significant immunological responses.
In the regulatory landscape defined by the FDA and other global health authorities, Solidago Virgaurea Flowering Top is categorized within a broad spectrum of drug classes. These include Non-Standardized Food Allergenic Extract [EPC], Central Nervous System Stimulant [EPC], and even Potassium-sparing Diuretic [EPC] contexts in traditional monographs. As a non-standardized extract, the potency is not measured by a universally accepted biological unit (like BAU), but rather by weight-to-volume (w/v) or protein nitrogen unit (PNU) concentrations. This means that different batches may vary in their specific antigenic load, requiring healthcare providers to exercise caution when transitioning patients between different manufacturers or lots.
Historically, Solidago has been utilized in traditional European medicine for its diuretic (increasing urine output) and anti-inflammatory properties. In modern clinical practice, however, its most prominent role is in the field of allergy and immunology. It is used as a diagnostic tool to identify patients who have developed IgE-mediated hypersensitivity to the plant's proteins and as a component of allergen immunotherapy (allergy shots) to desensitize the immune system over time.
The mechanism of action for Solidago Virgaurea Flowering Top is multifaceted, depending on its clinical application. When used as an allergenic extract, it functions through the modulation of the immune system. In a sensitized individual, the proteins within the extract bind to specific Immunoglobulin E (IgE) antibodies located on the surface of mast cells and basophils. This binding triggers a process called degranulation, where the cells release inflammatory mediators such as histamine, leukotrienes, and prostaglandins. This is the 'challenge' phase used in diagnostic skin testing.
For therapeutic immunotherapy, the mechanism shifts toward the induction of immune tolerance. Repeated, escalating exposure to the extract stimulates the production of Regulatory T-cells (Tregs) and the shift from a Th2 (allergic) immune response to a Th1 or T-regulatory response. This leads to the production of IgG4 antibodies, which act as 'blocking antibodies' to prevent IgE from binding to the allergen, thereby reducing the allergic symptoms upon future environmental exposure.
Furthermore, the provided pharmacological profile suggests activities such as Ammonium Ion Binding Activity [MoA] and Adrenergic alpha-Agonists [MoA]. At a molecular level, the flavonoids (like quercetin and kaempferol) and saponins found within the flowering tops are thought to inhibit certain enzymes and modulate ion channels, contributing to the plant's traditional use as an aquaretic (a type of diuretic that increases water excretion without significant electrolyte loss). The interaction with adrenergic receptors suggests a potential, albeit secondary, effect on vascular tone and smooth muscle contraction, which is why it is sometimes grouped with catecholamine-like substances in broad EPC classifications.
The pharmacokinetics of Solidago Virgaurea Flowering Top differ significantly from traditional synthetic drugs because it is a complex mixture of proteins, polysaccharides, and secondary metabolites.
Solidago Virgaurea Flowering Top is indicated for several clinical scenarios:
Solidago Virgaurea Flowering Top is available in several specialized formulations:
> Important: Only your healthcare provider can determine if Solidago Virgaurea Flowering Top is right for your specific condition. The use of allergenic extracts must be conducted under the supervision of a clinician trained in the management of anaphylaxis.
Dosage for Solidago Virgaurea Flowering Top is highly individualized and must be determined by an allergist or immunologist based on the patient's sensitivity levels.
Solidago Virgaurea Flowering Top is generally considered safe for use in children, provided the child is old enough to cooperate with the testing and treatment (usually 5 years and older). Dosage follows the same weight-to-volume escalation protocols as adults, but clinicians often use more conservative 'starting' dilutions to minimize the risk of systemic reactions in smaller patients. Clinical data for infants under 2 years of age is insufficient, and use is generally avoided in this population.
No specific dosage adjustments are provided for patients with renal impairment when using the allergenic extract. However, if using the substance for its diuretic properties, patients with a GFR < 30 mL/min should be monitored closely for electrolyte imbalances, as the 'Potassium-sparing' and 'Ammonium Ion Binding' properties may affect mineral homeostasis.
There are no established guidelines for dose modification in hepatic impairment for allergenic extracts. Since the primary route of action is immunological rather than metabolic, significant changes in efficacy or safety are not typically expected.
Geriatric patients may have reduced skin reactivity, which can lead to false-negative results in diagnostic testing. In immunotherapy, the presence of comorbid cardiovascular conditions (e.g., use of beta-blockers) is a more significant concern than age itself. The starting dose should be conservative.
In immunotherapy, timing is critical. If a dose is missed during the build-up phase, the next dose may need to be reduced to the previous level to maintain safety. If the maintenance dose is delayed by more than 1–2 weeks, the clinician may need to 'back-step' the dosage. Do not double the dose to catch up.
An overdose of Solidago Virgaurea Flowering Top usually manifests as an immediate and severe systemic allergic reaction.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. The potency of non-standardized extracts can vary between manufacturers.
Most patients receiving Solidago Virgaurea Flowering Top extracts will experience localized reactions. These are generally considered a normal part of the body's response to the allergen.
> Warning: Stop taking Solidago Virgaurea Flowering Top and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Solidago Virgaurea Flowering Top when used as an allergenic extract. The primary long-term risk is the development of a 'new' sensitivity to other components in the extract, though this is rare. Prolonged use in immunotherapy is intended to produce long-term immunological tolerance, which is a beneficial effect. If used orally in high doses for its diuretic properties, there is a theoretical risk of electrolyte depletion or 'Ammonium Ion' imbalances over time.
While Solidago Virgaurea Flowering Top itself may not have a specific individual black box warning, the class of Allergenic Extracts carries a general warning regarding the risk of severe life-threatening reactions.
FDA Class Warning Summary:
Report any unusual symptoms to your healthcare provider. Even a large local reaction should be reported, as it may be a precursor to a systemic reaction in future doses.
Solidago Virgaurea Flowering Top is intended for use only by clinicians experienced in the diagnosis and treatment of allergic diseases. Because it is a non-standardized extract, the risk of unexpected potency variations exists. Patients must be stable and free of acute respiratory infections before receiving an injection.
No specific FDA black box warning exists uniquely for Solidago Virgaurea Flowering Top; however, it falls under the mandatory class labeling for Allergenic Extracts. This labeling states that these products can cause anaphylaxis and must be administered in a setting equipped with emergency resuscitative equipment and by personnel trained in its use.
Generally, Solidago Virgaurea Flowering Top does not cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a physician.
Alcohol should be avoided on the day of an allergy injection. Alcohol causes vasodilation (widening of blood vessels), which can increase the rate of absorption of the allergen from the injection site, potentially increasing the risk of a systemic reaction.
Unlike many medications, allergenic extracts do not require a 'taper.' However, if treatment is stopped for an extended period (e.g., several months), the patient will lose their desensitization and must restart at the lowest 'build-up' dose. Stopping suddenly does not cause a withdrawal syndrome, but allergic symptoms will likely return upon environmental exposure.
> Important: Discuss all your medical conditions with your healthcare provider before starting Solidago Virgaurea Flowering Top, especially if you have a history of heart problems or asthma.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is vital for your safety during allergy treatment.
Patients allergic to Solidago Virgaurea Flowering Top often show cross-sensitivity to other members of the Asteraceae (Compositae) family. This includes:
If you have had a severe reaction to any of these plants, you must inform your doctor before testing with Solidago extract.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Solidago Virgaurea Flowering Top. Never attempt to self-administer allergenic extracts.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Solidago Virgaurea Flowering Top in pregnant women. Animal reproduction studies have not been conducted. The primary concern is not direct teratogenicity (birth defects) from the extract, but the danger of maternal anaphylaxis. A severe allergic reaction can cause a sudden drop in maternal blood pressure and uterine contraction, leading to fetal hypoxia (lack of oxygen) or miscarriage. Most clinicians recommend against starting the 'build-up' phase during pregnancy but may continue 'maintenance' doses if the patient is stable.
It is not known whether the components of Solidago Virgaurea Flowering Top are excreted in human milk. Because the allergenic proteins are large and typically degraded locally or in the lymphatics, systemic absorption is low. The risk to the nursing infant is considered minimal. However, the decision to continue immunotherapy while breastfeeding should be made after a risk-benefit discussion with a healthcare provider.
Solidago Virgaurea Flowering Top is used in children for both diagnosis and treatment. Clinical trials and observational data suggest that immunotherapy is effective in children for preventing the progression of allergic rhinitis to asthma (the 'allergic march'). Special care must be taken with dosing to avoid systemic reactions, as children may be less able to communicate early symptoms of anaphylaxis. Use in children under age 5 is generally limited due to the difficulty of administration and monitoring.
In patients over 65, the immune system's reactivity (both the allergic response and the response to immunotherapy) may be diminished (immunosenescence). Older adults are also more likely to have cardiovascular comorbidities and be taking medications like beta-blockers or ACE inhibitors, which increase the risks associated with immunotherapy. A thorough cardiac evaluation is recommended before starting treatment in this age group.
While the allergenic extract is not significantly cleared by the kidneys in its active form, the secondary metabolites of Solidago (flavonoids/saponins) are. Patients with end-stage renal disease (ESRD) or those on dialysis have not been specifically studied. If using Solidago for its traditional diuretic effects, it is generally contraindicated in cases of impaired heart or kidney function where fluid intake is restricted.
No dosage adjustments are established for hepatic impairment. The liver's role in processing the large proteins found in allergenic extracts is negligible, though it is involved in the metabolism of the plant's secondary metabolites. Standard clinical monitoring is sufficient.
> Important: Special populations require individualized medical assessment. Always inform your specialist about pregnancy or changes in your health status.
Solidago Virgaurea Flowering Top acts as a complex biological modifier. In the context of Non-Standardized Plant Allergenic Extract [EPC], its primary molecular target is the IgE-FcεRI complex on mast cells. During diagnostic testing, the extract cross-links IgE molecules, triggering calcium influx and degranulation.
In its role as a Potassium-sparing Diuretic [EPC] and Ammonium Ion Binding Agent [EPC], the flowering top contains leiocarposide and various saponins. These compounds are thought to act on the renal tubules to increase the glomerular filtration rate and inhibit the reabsorption of water, without the significant loss of potassium seen with 'loop' diuretics. The 'Ammonium Ion Binding' property suggests a role in modulating nitrogenous waste, although this is more common in traditional pharmacological descriptions than modern clinical immunology.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous); Negligible (Epicutaneous) |
| Protein Binding | N/A (Proteins are the active components) |
| Half-life | Variable (Proteins degraded within hours) |
| Tmax | 15-30 minutes (for local skin reaction) |
| Metabolism | Proteolysis (Proteins); Hepatic Phase II (Flavonoids) |
| Excretion | Renal (Metabolites) |
Solidago Virgaurea Flowering Top is classified as a Non-Standardized Plant Allergenic Extract. It shares this class with other common extracts like Ragweed, Timothy Grass, and Oak. It is distinct from 'Standardized' extracts, which have a labeled potency in Bioequivalent Allergy Units (BAU).
Medications containing this ingredient
Common questions about Solidago Virgaurea Flowering Top
Solidago Virgaurea Flowering Top is primarily used as an allergenic extract for the diagnosis and treatment of goldenrod pollen allergies. In a clinical setting, it is used in skin prick tests to confirm if a patient is allergic to this specific plant. It is also used in allergen immunotherapy, commonly known as allergy shots, to help desensitize the immune system over time. Beyond its use in allergy, it has historical uses in traditional medicine as a mild diuretic and anti-inflammatory for urinary tract health. However, its most common modern application is strictly within the field of immunology and allergy management.
The most common side effects are localized to the site of administration, whether it is for a skin test or an immunotherapy injection. Patients frequently experience redness, itching, and a raised bump (wheal) at the site, which usually resolves within a few hours. Some patients may also experience 'late-phase' reactions where swelling and soreness appear 6 to 24 hours later. While these local reactions are common and usually harmless, they should be monitored. Systemic side effects like sneezing or mild congestion are less common but can occur shortly after treatment.
It is generally advised to avoid alcohol consumption on the day you receive an injection of Solidago Virgaurea Flowering Top. Alcohol can cause your blood vessels to dilate (expand), which may speed up the absorption of the allergen into your bloodstream. This increased absorption rate can raise the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can mask the early symptoms of a reaction, making it harder for you to seek help. Always wait at least 24 hours after your injection before consuming alcohol to ensure maximum safety.
The use of Solidago Virgaurea Flowering Top during pregnancy is approached with significant caution. While the extract itself is not known to cause birth defects, the risk of a severe allergic reaction (anaphylaxis) poses a danger to both the mother and the fetus. Anaphylaxis can lead to a dangerous drop in blood pressure and reduced oxygen flow to the baby. For this reason, doctors usually do not start new allergy shots during pregnancy. If you are already on a stable maintenance dose, your allergist may decide to continue treatment, but you must discuss your pregnancy immediately with your healthcare provider.
The timeline for Solidago Virgaurea Flowering Top depends on the goal of the treatment. For diagnostic skin testing, the results are visible almost immediately, typically within 15 to 20 minutes. For therapeutic immunotherapy (allergy shots), the process is much slower. Most patients begin to feel a reduction in their allergy symptoms during the 'maintenance phase,' which usually takes 3 to 6 months of regular injections. To achieve long-lasting or permanent relief, a full course of treatment typically lasts between 3 and 5 years.
Yes, you can stop taking Solidago Virgaurea Flowering Top injections suddenly without experiencing physical withdrawal symptoms like those associated with narcotics or antidepressants. However, stopping treatment will halt the desensitization process. If you stop during the build-up phase or early in the maintenance phase, your allergy symptoms will likely return when you are exposed to goldenrod pollen in the environment. If you wish to stop treatment, you should discuss it with your allergist to determine if you have received enough therapy to maintain long-term benefits.
If you miss an immunotherapy dose of Solidago Virgaurea Flowering Top, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose. Because the safety of the treatment depends on a gradual increase in exposure, a significant gap between doses may require your doctor to reduce the dose for your next injection to ensure you don't have a reaction. The specific protocol for a missed dose depends on how long it has been since your last injection and whether you are in the build-up or maintenance phase.
There is no clinical evidence to suggest that Solidago Virgaurea Flowering Top allergenic extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are often used to treat allergies and can cause weight changes, allergenic extracts work on the immune system without affecting metabolism or appetite. If you experience unexpected weight gain while undergoing immunotherapy, it is likely due to other factors or medications, and you should consult your primary care physician to investigate the cause.
Solidago Virgaurea Flowering Top can be taken with many medications, but there are critical exceptions. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Antihistamines must be stopped several days before skin testing because they will block the test results. However, most routine medications for other conditions are compatible with allergy shots. Always provide your allergist with a complete and updated list of all medications and supplements you are using.
Solidago Virgaurea Flowering Top is a biological extract, and the concept of 'generic' works differently than it does for chemical pills. While multiple manufacturers may produce an extract of European Goldenrod, these are considered 'non-standardized' and are not exactly identical to one another. Because the protein content can vary between brands, you should not switch between different manufacturers' products without close medical supervision. Your allergist will typically stick with one reliable source for your entire course of treatment to ensure consistency and safety.